See more : Samsung Electro-Mechanics Co., Ltd. (009150.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Dalrada Financial Corporation (DFCO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dalrada Financial Corporation, a leading company in the Consulting Services industry within the Industrials sector.
You may be interested
- Customers Bancorp, Inc 5.375% S (CUBB) Income Statement Analysis – Financial Results
- Sun Race Sturmey-Archer Corporation (1526.TW) Income Statement Analysis – Financial Results
- BKM Industries Limited (BKMINDST.NS) Income Statement Analysis – Financial Results
- Diageo plc (GUI.DE) Income Statement Analysis – Financial Results
- Kyushu Electric Power Company, Incorporated (KYSEF) Income Statement Analysis – Financial Results
Dalrada Financial Corporation (DFCO)
About Dalrada Financial Corporation
Dalrada Financial Corporation and its subsidiaries provide clean energy, healthcare, technology, and precision engineering solutions. It operates through Engineering, Health, Information Technology, Education, and Corporate. The company engages in the manufacture and distribution of medical disposables, hospital equipment and furniture, medical devices, and laboratory and dental products, as well as sanitizing, disinfectant, and PPE products and services; and provision of mechanical contract services. It also provides advanced solutions for the harvesting and recycling of energy to maximize the capture and reuse of thermal energy for integrated heating and cooling applications, such as industrial, commercial, and residential sectors. In addition, the company offers software and technology solutions that specializes in test engineering, accessibility engineering, product engineering and application modernization; cleaning solutions using electrostatic machines to spray and deodorize residential spaces, healthcare facilities, hospitality, transportation, manufacturing, automotive, schools/education systems, and other facilities. Further, it provides trained nursing and medical assistants for hospitals and home health facilities; and regenerative therapy as a potential solution for the prevention, detection, and treatment of cellular breakdown associated with aging and various other conditions, as well as explores various products and services within the immunization and personal protective equipment industry. The company has operations in Malaysia, India, the United Kingdom, and the United States. Dalrada Financial Corporation was founded in 1982 and is based in Escondido, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.74M | 19.27M | 3.41M | 1.18M | 72.16K | 0.00 | 70.38M | 19.48M | 13.53M | 4.19M | 25.25M | 3.45M | 2.55M | 17.30M | 34.40M | 30.60M | 11.60M | 14.40M | 11.10M | 10.20M | 10.30M | 7.20M | 10.50M | 9.50M | 9.30M | 4.20M | 1.80M |
| Cost of Revenue | 20.68M | 8.76M | 2.47M | 625.92K | 75.00K | 0.00 | 63.93M | 16.53M | 10.30M | 2.30M | 23.20M | 2.74M | 1.87M | 13.30M | 21.80M | 15.50M | 9.60M | 11.60M | 9.80M | 4.70M | 4.90M | 5.50M | 8.10M | 8.10M | 7.20M | 2.80M | 1.40M |
| Gross Profit | 9.06M | 10.51M | 934.72K | 552.24K | -2.84K | 0.00 | 6.45M | 2.95M | 3.22M | 1.89M | 2.05M | 710.00K | 679.00K | 4.00M | 12.60M | 15.10M | 2.00M | 2.80M | 1.30M | 5.50M | 5.40M | 1.70M | 2.40M | 1.40M | 2.10M | 1.40M | 400.00K |
| Gross Profit Ratio | 30.46% | 54.53% | 27.44% | 46.87% | -3.94% | 0.00% | 9.17% | 15.13% | 23.84% | 45.13% | 8.13% | 20.57% | 26.66% | 23.12% | 36.63% | 49.35% | 17.24% | 19.44% | 11.71% | 53.92% | 52.43% | 23.61% | 22.86% | 14.74% | 22.58% | 33.33% | 22.22% |
| Research & Development | 120.00K | 657.00K | 520.51K | 471.96K | 50.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 250.00K | 2.05M | 2.20M | 2.50M | 4.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 29.47M | 20.07M | 8.98M | 2.77M | 721.85K | 91.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 29.47M | 20.07M | 8.98M | 2.77M | 721.85K | 91.98K | 11.19M | 5.58M | 4.20M | 7.59M | 12.44M | 8.72M | 7.78M | 13.70M | 10.30M | 9.40M | 3.20M | 4.40M | 4.40M | 4.40M | 4.40M | 6.00M | 5.20M | 3.50M | 3.80M | 2.90M | 1.70M |
| Other Expenses | 433.56K | 308.53K | 114.40K | 1.23M | 2.26M | -183.97K | 0.00 | 1.35M | 0.00 | 0.00 | 0.00 | 0.00 | 3.33M | 4.80M | 700.00K | 900.00K | 400.00K | 800.00K | 700.00K | 300.00K | 200.00K | 300.00K | 100.00K | 200.00K | 200.00K | 200.00K | 200.00K |
| Operating Expenses | 30.02M | 20.72M | 9.50M | 3.24M | 771.90K | 91.98K | 11.19M | 6.93M | 4.20M | 7.59M | 12.44M | 8.97M | 13.16M | 20.70M | 13.50M | 14.50M | 3.60M | 5.20M | 5.10M | 4.70M | 4.60M | 6.30M | 5.30M | 3.70M | 4.00M | 3.10M | 1.90M |
| Cost & Expenses | 50.70M | 29.48M | 11.98M | 3.87M | 846.89K | 91.98K | 75.12M | 23.46M | 14.50M | 9.89M | 35.64M | 11.71M | 15.03M | 34.00M | 35.30M | 30.00M | 13.20M | 16.80M | 14.90M | 9.40M | 9.50M | 11.80M | 13.40M | 11.80M | 11.20M | 5.90M | 3.30M |
| Interest Income | 79.76K | 4.45K | 6.28K | 8.77K | 853.18K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.55M | 1.30M | 670.27K | 1.04M | 853.18K | 945.24K | 2.70M | 1.71M | 1.93M | 0.00 | 3.30M | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | 100.00K | 100.00K | 100.00K | 0.00 | 0.00 | 400.00K | 400.00K | 300.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 707.57K | 252.94K | 112.50K | 46.60K | 774.74K | 91.98K | 1.34M | 510.00K | 1.18M | 1.07M | 972.00K | 806.00K | 3.33M | 4.80M | 700.00K | 900.00K | -400.00K | -800.00K | -700.00K | -300.00K | -200.00K | 300.00K | 100.00K | 200.00K | 200.00K | 200.00K | 200.00K |
| EBITDA | -17.37M | -9.88M | 783.99K | -1.39M | 1.22M | -91.98K | -3.40M | -3.47M | 203.00K | -4.62M | -9.42M | -7.45M | -9.16M | -11.90M | -200.00K | 1.40M | -1.20M | -1.60M | -3.10M | 1.10M | 1.00M | -4.30M | -2.80M | -2.10M | -1.70M | -1.50M | -1.30M |
| EBITDA Ratio | -58.40% | -49.73% | -243.88% | -223.53% | -1,073.71% | 0.00% | -19.69% | -18.15% | 1.45% | -166.85% | -37.29% | -168.77% | -364.90% | -32.37% | 25.58% | 4.58% | 7.76% | -11.11% | -27.93% | 10.78% | 16.50% | -55.56% | -49.52% | -41.05% | -35.48% | -54.76% | -100.00% |
| Operating Income | -20.96M | -10.22M | -8.57M | -2.69M | -774.74K | -91.98K | -4.74M | -3.98M | -972.00K | -5.70M | -10.39M | -8.26M | -12.48M | -16.70M | -900.00K | 600.00K | -1.60M | -2.40M | -3.80M | 800.00K | 800.00K | -4.60M | -2.90M | -2.30M | -1.90M | -1.70M | -1.50M |
| Operating Income Ratio | -70.48% | -53.03% | -251.57% | -228.23% | -1,073.71% | 0.00% | -6.73% | -20.44% | -7.19% | -135.92% | -41.14% | -239.28% | -490.15% | -96.53% | -2.62% | 1.96% | -13.79% | -16.67% | -34.23% | 7.84% | 7.77% | -63.89% | -27.62% | -24.21% | -20.43% | -40.48% | -83.33% |
| Total Other Income/Expenses | 332.24K | -1.00M | 8.57M | 211.54K | 1.14M | -945.24K | 7.77M | -121.00K | -1.92M | -1.16M | -3.30M | -1.63M | -1.71M | -8.10M | -9.00M | -13.00K | -2.10M | 0.00 | 0.00 | 0.00 | -700.00K | -300.00K | 2.10M | 1.80M | 1.60M | 800.00K | 500.00K |
| Income Before Tax | -20.63M | -11.44M | 1.22K | -2.48M | 365.85K | -1.04M | 3.03M | -4.28M | -2.90M | -6.86M | -13.69M | -9.89M | -12.35M | -24.80M | -9.90M | 600.00K | -3.70M | 0.00 | 0.00 | 800.00K | 100.00K | -4.90M | -800.00K | -500.00K | -300.00K | -900.00K | -1.00M |
| Income Before Tax Ratio | -69.36% | -59.37% | 0.04% | -210.29% | 507.03% | 0.00% | 4.30% | -21.96% | -21.40% | -163.60% | -54.20% | -286.44% | -484.69% | -143.35% | -28.78% | 1.96% | -31.90% | 0.00% | 0.00% | 7.84% | 0.97% | -68.06% | -7.62% | -5.26% | -3.23% | -21.43% | -55.56% |
| Income Tax Expense | 0.00 | 132.51K | 694.46K | 1.03M | -1.99M | -91.98K | 40.00K | 238.00K | -1.07M | 1.16M | 0.00 | 1.63M | 1.71M | 300.00K | 9.30M | -200.00K | 2.80M | 1.30M | 1.60M | 100.00K | 1.10M | 800.00K | 100.00K | -1.40M | -1.50M | -900.00K | -500.00K |
| Net Income | -20.29M | -11.57M | -693.24K | -3.51M | 2.36M | -1.04M | 2.62M | -4.22M | 102.00K | -6.86M | -13.69M | -9.89M | -14.20M | -25.10M | -10.20M | 800.00K | -3.60M | -2.10M | -4.00M | 700.00K | 100.00K | -5.40M | -900.00K | -900.00K | -400.00K | -800.00K | -1.00M |
| Net Income Ratio | -68.24% | -60.06% | -20.35% | -297.76% | 3,270.20% | 0.00% | 3.73% | -21.66% | 0.75% | -163.60% | -54.20% | -286.44% | -557.44% | -145.09% | -29.65% | 2.61% | -31.03% | -14.58% | -36.04% | 6.86% | 0.97% | -75.00% | -8.57% | -9.47% | -4.30% | -19.05% | -55.56% |
| EPS | -0.24 | -0.16 | -0.01 | -0.06 | 0.05 | -0.02 | 0.63 | -1.28 | 0.06 | -14.23 | -224.38 | -300.80 | -545.05 | -6.48K | -3.60K | 280.00 | -1.26K | -735.04 | -1.40K | 245.01 | 35.00 | -1.89K | -315.02 | -315.02 | -140.01 | -280.01 | -350.02 |
| EPS Diluted | -0.24 | -0.16 | -0.01 | -0.06 | 0.02 | -0.02 | 0.35 | -1.28 | 0.06 | -14.23 | -224.38 | -300.80 | -545.05 | -6.48K | -3.60K | 240.00 | -1.26K | -735.04 | -1.40K | 245.01 | 35.00 | -1.89K | -315.02 | -315.02 | -140.01 | -280.01 | -350.02 |
| Weighted Avg Shares Out | 83.76M | 72.22M | 70.32M | 56.80M | 47.43M | 47.28M | 4.11M | 3.29M | 1.66M | 481.58K | 61.01K | 32.87K | 26.05K | 3.87K | 2.83K | 2.50K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K |
| Weighted Avg Shares Out (Dil) | 83.76M | 72.22M | 128.95M | 56.80M | 102.58M | 47.28M | 19.35M | 3.29M | 1.66M | 481.58K | 61.01K | 32.87K | 26.05K | 3.87K | 2.83K | 2.92K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K |
Dalrada achieves FY21 net profit on triple-digit revenue increase
Dalrada Corporation achieved a net profit after generating a triple-digit increase in revenue during its fiscal year 2021, underscoring its growth and momentum. For its FY ended June 30, the company said it banked revenues of $3,406,684 -- a 189%...
Dalrada Corporation Reports Increase of 189% in Revenues and a Net Operating Profit in Audited Fiscal 2021 Financials
SAN DIEGO--(BUSINESS WIRE)---- $DFCO #2021fiscalyear--Dalrada Corporation (OTCQB: DFCO, “Dalrada”) has reported financial results for the fiscal year 2021. Dalrada's subsidiaries – Dalrada Precision, Dalrada Health, and Dalrada Technology – provide high-value, innovative, alternative solutions to institutions, businesses, and consumers worldwide....
Dalrada reveals successful coronavirus testing initiative at the Boise Pride Festival and Parade
Dalrada Corporation has announced that its Pala Diagnostics LLC joint venture with Vivera Pharmaceuticals Inc performed both reverse transcription-polymerase chain reaction (RT-PCR) tests and US Food and Drug Administration (FDA)-authorized Antigen tests throughout the three-day Boise Pride Festival and Parade in Idaho. Dalrada noted that...
Dalrada Corporation's Pala Diagnostics Free COVID-19 Point-of-care Tests Proved Compliance for Nearly 3,000 Outdoor Festival Attendees
SAN DIEGO--(BUSINESS WIRE)---- $DFCO #CLIAlab--Dalrada Corporation (OTCQB: DFCO, “Dalrada”) is excited to share information on the Company's community outreach efforts that support free, on-site COVID-19 point-of-care tests at in-person events. Pala Diagnostics, LLC (“Pala Diagnostics”), a joint venture between Dalrada...
Dalrada Health Expands Operations With Openings of Pala Diagnostics Laboratory and Sòlas Rejuvenation and Wellness Center
SAN DIEGO--(BUSINESS WIRE)---- $DFCO #24hourtest--Dalrada Corporation (OTCQB: DFCO) (“Dalrada”) would like to update its shareholders and the public that its subsidiary, Dalrada Health, expanded its operations with the opening of two new subsidiaries. Pala Diagnostics, LLC (“Pala Diagnostics”) is a...
Dalrada subsidiary Prakat Solutions partners with ValueQwest for digital transformation of global supply chains
Dalrada Corporation (OTCQB:DFCO) has announced that its IT engineering subsidiary Prakat Solutions Inc has partnered with Singapore-based ValueQwest Private Limited to expand the digital transformation of global supply chains. According to a report by Global Industry Analysts, digital transformation is...
Dalrada taps Captain David Bacon to its board as it advances its health product lines
Dalrada Corporation (OTCQB:DFCO) said that it has appointed well-known medical expert and US Navy Captain Dr David Bacon to the company's board, as the group focuses on advancing Dalrada Health's product lines. Dr Bacon is an active US Navy Captain...
Dalrada taps Captain David Bacon to the company's board as it advances its health product lines
Dalrada Corporation (OTCQB:DFCO) said that it has appointed well-known medical expert and US Navy Captain Dr David Bacon to the company's board, as the group focuses on advancing Dalrada Health's product lines. Dr Bacon is an active US Navy Captain...
Dalrada Corporation says subsidiary Prakat Solutions will sponsor virtual Global Accessibility Awareness Day event
Dalrada Corporation (OTCQB:DFCO) said its subsidiary Prakat Solutions Inc will host and sponsor its annual virtual Global Accessibility Awareness Day (GAAD) event to commemorate its commitment to resolving accessibility challenges around the world. For the event, Prakat and Dalrada will partner...
Dalrada Corporation says Kyle McCollum has accepted the role as the company's chief financial officer
Dalrada Corporation (OTCQB:DFCO) announced that Kyle McCollum has accepted the role as the company's chief financial officer. Holding nearly two decades of experience in domestic and international business with a focus on accounting, finance, and management, McCollum's background also includes investment...
Source: https://incomestatements.info
Category: Stock Reports